{
  "docId": "019de070-14f8-7659-9020-5924af9296cd",
  "docSlug": "a0353e82ff2da767329aa025539c408b",
  "documentTitle": "Legend Biotech | IPO Presentation Deck | 42 slides",
  "authorId": "legend-biotech",
  "authorName": "Legend Biotech",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investment_bank",
  "sourceTypeLabel": "Investment bank",
  "presentationDate": "2020-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 42,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "solution",
  "function": "present_solution",
  "density": "dense",
  "nDataPoints": 0,
  "notes": "The diagram uses a circular flow process to represent the R&D pipeline stages.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de070-14f8-7659-9020-5924af9296cd/7",
  "deckHref": "/decks/019de070-14f8-7659-9020-5924af9296cd",
  "deckJsonHref": "/decks/019de070-14f8-7659-9020-5924af9296cd.json",
  "deckAnchorHref": "/decks/019de070-14f8-7659-9020-5924af9296cd#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.7,
        "x": 0.15,
        "y": 0.25
      },
      "kind": "diagram",
      "text": "Circular flow diagram showing four stages: Antibody Screening Platforms, Binding Domain Selection and Construct Design, Pre-clinical Validation, and Clinical Proof of Concept.",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "3b381ded-3608-4830-bc6d-6be7b7763764",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.15,
        "y": 0.15
      },
      "kind": "paragraph",
      "text": "High-throughput antibody screening and engineering capability including single-domain antibodies generated from Llama and conventional antibodies",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4a6421e1-2b85-4953-bdb3-b8ec883823c1",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.25,
        "x": 0.62,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Efficient clinical translation, leveraging deep relationships with KOLs in China",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7a54eac5-e4eb-4c76-8f04-9e926f450cb6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.3,
        "x": 0.25,
        "y": 0.82
      },
      "kind": "paragraph",
      "text": "Proprietary methodology to optimize the selection of binding domains and design CAR-T constructs with two or more antigen-binding domains",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d440bd6e-765e-4f03-a3b7-73a89def7350",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.1,
        "w": 0.2,
        "x": 0.48,
        "y": 0.18
      },
      "kind": "paragraph",
      "text": "Robust in vitro and in vivo screening platforms to prioritize pipeline assets",
      "attrs": null,
      "subkind": "paragraph",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "dfc7224d-a489-4ad9-a848-ea02f3d6afb5",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.055,
        "w": 0.386,
        "x": 0.307,
        "y": 0.035
      },
      "kind": "title",
      "text": "End-to-end R&D Capability",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "a1d80f36-e534-487c-a75e-d179f434214b",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Process flow",
      "slug": "process-flow",
      "agent": null,
      "layer": "slide",
      "matchId": "e0324284-fd36-4f29-8429-c18b53274dbb",
      "evidence": "diagram/process: Circular flow diagram showing four stages: Antibody Screening Platforms, Binding Domain Selection and Construct Design, Pre-clinical Validation, and Clinical Proof of Concept.",
      "confidence": 0.8
    }
  ],
  "frameworks": [
    {
      "name": "process",
      "slug": null,
      "matchId": "48d237a7-b934-4605-95a6-12ec5e8b8220",
      "evidence": "Circular flow diagram representing R&D stages",
      "confidence": 0.8
    }
  ],
  "arcBeats": [
    {
      "to": 7,
      "from": 7,
      "beatId": "b4cd700d-83ea-417c-bdc4-27a02a75b43b",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The solution is presented on page 7: End-to-end R&D Capability",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}